Key facts
- Cern Corporation’s last known valuation is $20.0M (Feb 2026).
- It has raised $920K; the latest was Seed Round ($3.0M) in Feb 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Cern Corporation
- ·The full record, as it builds
Funding rounds
No funding rounds for Cern Corporation are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cern Corporation
Developer of a non-drug device and gel therapeutic designed to treat fungal and bacterial vaginosis. The company offers a localized, drug-free mechanism that avoids systemic exposure and supports remote health applications, enabling women seeking alternatives to oral and topical medications safer and more convenient treatment options.
- Sector
- Healthcare
- HQ
- Coto de Caza, CA, United States
- Founded
- 2019
- Employees
- 5
- Website
- cerndevice.com/
- Ownership
- Privately Held (backing)
Cern Corporation doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cern Corporation shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cern Corporation in its N-PORT filings yet. We sweep new filings monthly.